• Xu Y, Derakhshan A, Hysaj O, Wildisen L, Ittermann T, Pingitore A, Abolhassani N, Medici M, Kiemeney LALM, Riksen NP, Dullaart RPF, Trompet S, Dörr M, Brown SJ, Schmidt B, Führer-Sakel D, Vanderpump MPJ, Muendlein A, Drexel H, Fink HA, Ikram MK, Kavousi M, Rhee CM, Bensenor IM, Azizi F, Hankey GJ, Iacoviello M, Imaizumi M, Ceresini G, Ferrucci L, Sgarbi JA, Bauer DC, Wareham N, Boelaert K, Bakker SJL, Jukema JW, Vaes B, Iervasi G, Yeap BB, Westendorp RGJ, Korevaar TIM, Völzke H, Razvi S, Gussekloo J, Walsh JP, Cappola AR, Rodondi N, Peeters RP, Chaker L, Thyroid Studies Collaboration. The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis. The lancet. Diabetes & endocrinology. 2023 Sep 8.
• Hegde SM, Claggett BL, Udell JA, Kim K, Joseph J, Farkouh ME, Peikert A, Bhatt AS, Tattersall MC, Bhatt DL, Cooper LS, Solomon SD, Vardeny O. Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. 2023 Sep 5; 6(9):e2331284.
• Frank DA, Johnson AE, Hausmann LRM, Gellad WF, Roberts ET, Vajravelu RK. Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender : A Nationally Representative Cross-Sectional Analysis of Adults in the United States. Annals of internal medicine. 2023 Aug 1; 176(8):1057-1066.
• Forman DE, Kuchel GA, Newman JC, Kirkland JL, Volpi E, Taffet GE, Barzilai N, Pandey A, Kitzman DW, Libby P, Ferrucci L. Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement. Journal of the American College of Cardiology. 2023 Aug 15; 82(7):631-647.
• Luo J, Feldman R, Callaway Kim K, Rothenberger S, Korytkowski M, Hernandez I, Gellad WF. Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease. JAMA Network Open. 2023 Jun 1; 6(6):e2317886.

» View more Citations

• Individualized Provider Reminders Improve Statin Use and Adherence among Veterans with Atherosclerotic Cardiovascular Disease
  This multi-site trial compared usual care to personalized reminders to providers in improving the use of high-intensity statins in Veterans with atherosclerotic cardiovascular disease (ASCVD). Findings showed that centrally processed individualized reminders to providers led to a significant increase in high-intensity statin (HIS) use and statin adherence among Veterans with ASCVD. In the interven...
  
  Date: March 5, 2023
• Traumatic Brain Injury May Be a Potentially Novel Risk Factor for Cardiovascular Disease in Veterans
  This study sought to determine the association between TBI and subsequent cardiovascular disease (CVD) in post-9/11 era Veterans. Findings showed that post-9/11 Veterans with mild TBI, moderate to severe TBI, and penetrating TBI were more likely to develop CVD compared to Veterans without TBI. Although the risk was highest shortly after injury, TBI remained significantly associated with CVD for ye...
  
  Date: September 6, 2022
• Excess Mortality Rates among Post-9/11 Veterans Compared with General US Population, Particularly among Veterans with TBI
  This study sought to assess the total all-cause and cause-specific mortality burden – and to estimate the total number of excess deaths among post-9/11 Veterans with and without exposure to traumatic brain injury (TBI) compared with the total US population. Findings showed that post-9/11 Veterans experienced excess all-cause and cause-specific mortality compared with the total US population, which...
  
  Date: February 11, 2022
• Increased Risk for Cardiovascular Conditions among Veterans for Up to One Year Following COVID-19 Infection
  This study evaluated the risks and 12-month burdens of cardiovascular outcomes among Veterans who survived the first 30 days of COVID compared to VA healthcare users with no COVID and Veterans who used VA healthcare before the COVID pandemic. Findings showed that COVID-19 increased the risk of developing cardiovascular conditions – spanning several categories – within the first month to one year a...
  
  Date: February 7, 2022
• Women Veterans with Premature Cardiovascular Disease Less Likely than Men to Receive Secondary Prevention Therapy
  This study sought to evaluate sex-based differences in antiplatelet use, any statin and high-intensity statin (HIS) therapy, and statin adherence among patients with premature and extremely premature atherosclerotic cardiovascular disease (ASCVD). Findings showed that women Veterans with premature (age < 55 years) and extremely premature (age < 40 years) ASCVD were less likely to receive antiplate...
  
  Date: April 21, 2021

» View more Publication Briefs

» View more Studies

• Process Access Data

  ...white chronic obstructive pulmonary disease patients within the Veterans Administration... 2012;79(2):138-144. 2162 Cardiovascular disease x x VA-wide October 2006-September

• Mindfulness-based Stress Reduction for Women at Risk for Cardiovascular Disease || In Progress

  Reduction for Women at Risk for Cardiovascular Disease Feature Article Evidence demonstrates...processes implicated in coronary artery disease and stroke. Veterans who have experienced

• AppendixIV-EvidenceTables.xls

  ...as occurring because of injury or disease that incurred or was aggravated during...history of GI bleeding or peptic ulcer disease diagnosed in the previous year, use

• Management Briefs eBrief-no46 -- Treatment of Anemia in Patients with Heart Disease

  Treatment of Anemia in Patients with Heart Disease...with Heart Disease Anemia is very common in patients with heart disease. About one-third...to 20% of those with coronary heart disease (CHD) are anemic. Anemia in patients

• Management Briefs eBrief-no106 -- Pharmacist-Led Chronic Disease Management: Effectiveness and Harms Compared to Usual Care

  ...eBrief-no106 -- Pharmacist-Led Chronic Disease Management: Effectiveness and Harms...Synthesis Program. Pharmacist-Led Chronic Disease Management: Effectiveness and Harms...found that pharmacist-led chronic disease management was generally similar to

» View more Publications

» View more Cyberseminars

Videos

There are currently no videos for this topic.

Podcasts

There are currently no podcasts for this topic.

Other Resources

• VA and DoD agree on a common set of practice guidelines for a specific group of health conditions. Learn more about those guidelines here. 
• Visit the VA's Office of Research & Development healthcare topic overview section to learn more about milestones in VA heart disease research, read research updates, and download research fact sheets.
• Visit the ↑   Top
  
  
  Questions about the HSR&D website? Email the Web Team
  
  Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.